Non-invasive dynamic near-infrared imaging and quantification of vascular leakage in vivo

Angiogenesis

Volumn 16, Issue 3, 2013, Pages 525-540

  Proulx, Steven T ^a   Luciani, Paola ^a   Alitalo, Annamari ^a   Mumprecht, Viviane ^a   Christiansen, Ailsa J ^a   Huggenberger, Reto ^a   Leroux, Jean Christophe ^a   Detmar, Michael ^a  

^a ETH ZURICH   (Switzerland)

Author keywords

Imaging; Inflammation; Vascular permeability; VEGF A; VEGF C

Indexed keywords

IRDYE 800CW; MACROGOL DERIVATIVE; P20 D800; P40 D800; RECOMBINANT VASCULOTROPIN; TRACER; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BLOOD VOLUME; BREAST CANCER; CONTROLLED STUDY; DERMATITIS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; EAR; FEMALE; GENE OVEREXPRESSION; IN VIVO STUDY; LEG BLOOD VESSEL; LYMPH FLOW; LYMPH VESSEL; MOUSE; NEAR INFRARED SPECTROSCOPY; NON INVASIVE MEASUREMENT; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SKIN BLOOD VESSEL; TRANSGENIC MOUSE; VASCULAR DISEASE; VASCULAR LEAKAGE; VASCULARIZATION;

ANALYSIS OF VARIANCE; ANIMALS; CAPILLARY LEAK SYNDROME; CAPILLARY PERMEABILITY; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIAGNOSTIC IMAGING; DIMETHYL SULFOXIDE; FEMALE; INDOLES; INFRARED RAYS; LYMPHATIC VESSELS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; POLYETHYLENE GLYCOLS; SKIN; SPECTROPHOTOMETRY, ULTRAVIOLET; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR C;

MUS; MUS MUSCULUS;

EID: 84879237152     PISSN: 09696970     EISSN: 15737209     Source Type: Journal    
DOI: 10.1007/s10456-013-9332-2     Document Type: Article

References (47)

1. Yuan SY, Rigor RR (2010) In: Regulation of Endothelial Barrier Function. Integrated Systems Physiology: From Molecule to Function to Disease. San Rafael,CA
2. Levick JR, Michel CC (2010) Microvascular fluid exchange and the revised Starling principle. Cardiovasc Res 87(2):198-210. doi: 10.1093/cvr/cvq062
3. Scallan J, Huxley VH, Korthuis RJ (2010). In: Capillary fluid exchange: regulation, functions, and pathology. Integrated systems physiology: from molecule to function to disease. San Rafael, CA
4. Nagy JA, Dvorak AM, Dvorak HF (2007) VEGF-A and the induction of pathological angiogenesis. Annu Rev Pathol 2:251-275. doi: 10.1146/annurev. pathol.2.010506.134925
5. Dejana E, Tournier-Lasserve E, Weinstein BM (2009) The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Dev Cell 16(2):209-221. doi: 10.1016/j.devcel.2009. 01.004
6. Miles AA, Miles EM (1952) Vascular reactions to histamine, histamine-liberator and leukotaxine in the skin of guinea-pigs. J Physiol 118(2):228-257
7. Nagy JA, Benjamin L, Zeng H, Dvorak AM, Dvorak HF (2008) Vascular permeability, vascular hyperpermeability and angiogenesis. Angiogenesis 11(2):109-119. doi: 10.1007/s10456-008-9099-z
8. Bates DO (2010) Vascular endothelial growth factors and vascular permeability. Cardiovasc Res 87(2):262-271. doi: 10.1093/cvr/cvq105
9. Curry FR, Adamson RH (2010) Vascular permeability modulation at the cell, microvessel, or whole organ level: towards closing gaps in our knowledge. Cardiovasc Res 87(2):218-229. doi: 10.1093/cvr/cvq115
10. Kenne E, Lindbom L (2011) Imaging inflammatory plasma leakage in vivo. Thromb Haemost 105(5):783-789. doi: 10.1160/TH10-10-0635
11. Neeman M, Dafni H (2003) Structural, functional, and molecular MR imaging of the microvasculature. Annu Rev Biomed Eng 5:29-56. doi: 10.1146/annurev. bioeng.5.040202.121606
12. Mulder WJ, Griffioen AW (2010) Imaging of angiogenesis. Angiogenesis 13(2):71-74. doi: 10.1007/s10456-010-9178-9
13. Dreher MR, Liu W, Michelich CR, Dewhirst MW, Yuan F, Chilkoti A (2006) Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst 98(5):335-344. doi: 10.1093/jnci/djj070
14. Vandoorne K, Addadi Y, Neeman M (2010) Visualizing vascular permeability and lymphatic drainage using labeled serum albumin. Angiogenesis 13(2):75-85. doi: 10.1007/s10456-010-9170-4
15. Hilderbrand SA, Weissleder R (2010) Near-infrared fluorescence: application to in vivo molecular imaging. Curr Opin Chem Biol 14(1):71-79. doi: 10.1016/j.cbpa.2009.09.029
16. Cherrick GR, Stein SW, Leevy CM, Davidson CS (1960) Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. J Clin Invest 39:592-600. doi: 10.1172/JCI104072
17. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, Swartz M, Fukumura D, Jain RK, Alitalo K (1997) Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 276(5317):1423-1425
18. Xia YP, Li B, Hylton D, Detmar M, Yancopoulos GD, Rudge JS (2003) Transgenic delivery of VEGF to mouse skin leads to an inflammatory condition resembling human psoriasis. Blood 102(1):161-168. doi: 10.1182/blood-2002-12- 3793
19. Thurston G, Suri C, Smith K, McClain J, Sato TN, Yancopoulos GD, McDonald DM (1999) Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1. Science 286(5449):2511-2514
20. Wyatt SK, Manning HC, Bai M, Bailey SN, Gallant P, Ma G, McIntosh L, Bornhop DJ (2010) Molecular imaging of the translocator protein (TSPO) in a pre-clinical model of breast cancer. Mol Imaging Biol 12(3):349-358. doi: 10.1007/s11307-009-0270-8
21. Ott P, Keiding S, Bass L (1993) Plasma elimination of indocyanine green in the intact pig after bolus injection and during constant infusion: comparison of spectrophotometry and high-pressure liquid chromatography for concentration analysis. Hepatology 18(6):1504-1515. doi: 10.1002/hep.1840180633
22. Kunstfeld R, Hirakawa S, Hong YK, Schacht V, Lange-Asschenfeldt B, Velasco P, Lin C, Fiebiger E, Wei X, Wu Y, Hicklin D, Bohlen P, Detmar M (2004) Induction of cutaneous delayed-type hypersensitivity reactions in VEGF-A transgenic mice results in chronic skin inflammation associated with persistent lymphatic hyperplasia. Blood 104(4):1048-1057. doi: 10.1182/blood-2003-08-2964
23. Detmar M, Brown LF, Schon MP, Elicker BM, Velasco P, Richard L, Fukumura D, Monsky W, Claffey KP, Jain RK (1998) Increased microvascular density and enhanced leukocyte rolling and adhesion in the skin of VEGF transgenic mice. J Invest Dermatol 111(1):1-6. doi: 10.1046/j.1523-1747.1998.00262.x
24. Halin C, Detmar M (2008) Chapter 1. Inflammation, angiogenesis, and lymphangiogenesis. Methods Enzymol 445:1-25. doi: 10.1016/S0076-6879(08)03001-2
25. Dafni H, Landsman L, Schechter B, Kohen F, Neeman M (2002) MRI and fluorescence microscopy of the acute vascular response to VEGF165: vasodilation, hyper-permeability and lymphatic uptake, followed by rapid inactivation of the growth factor. NMR Biomed 15(2):120-131
26. Lohela M, Helotera H, Haiko P, Dumont DJ, Alitalo K (2008) Transgenic induction of vascular endothelial growth factor-C is strongly angiogenic in mouse embryos but leads to persistent lymphatic hyperplasia in adult tissues. Am J Pathol 173(6):1891-1901. doi: 10.2353/ajpath.2008.080378
27. Huggenberger R, Siddiqui SS, Brander D, Ullmann S, Zimmermann K, Antsiferova M, Werner S, Alitalo K, Detmar M (2011) An important role of lymphatic vessel activation in limiting acute inflammation. Blood 117(17):4667-4678. doi: 10.1182/blood-2010-10-316356
28. Krynyckyi BR, Kim CK, Goyenechea MR, Chan PT, Zhang ZY, Machac J (2004) Clinical breast lymphoscintigraphy: optimal techniques for performing studies, image atlas, and analysis of images. Radiographics 24 (1):121-145; discussion 139-145. doi: 10.1148/rg.241025713
29. Karlsen TV, McCormack E, Mujic M, Tenstad O, Wiig H (2011) Minimally-invasive quantification of lymph flow in mice and rats by imaging depot clearance of near-infrared albumin. Am J Physiol Heart Circ Physiol. doi: 10.1152/ajpheart.00842.2011
30. Tammela T, Alitalo K (2010) Lymphangiogenesis: molecular mechanisms and future promise. Cell 140(4):460-476. doi: 10.1016/j.cell.2010.01.045
31. Joukov V, Kumar V, Sorsa T, Arighi E, Weich H, Saksela O, Alitalo K (1998) A recombinant mutant vascular endothelial growth factor-C that has lost vascular endothelial growth factor receptor-2 binding, activation, and vascular permeability activities. J Biol Chem 273(12):6599-6602
32. Saxena V, Sadoqi M, Shao J (2003) Degradation kinetics of indocyanine green in aqueous solution. J Pharm Sci 92(10):2090-2097. doi: 10.1002/jps.10470
33. Troyan SL, Kianzad V, Gibbs-Strauss SL, Gioux S, Matsui A, Oketokoun R, Ngo L, Khamene A, Azar F, Frangioni JV (2009) The FLARE intraoperative near-infrared fluorescence imaging system: a first-in-human clinical trial in breast cancer sentinel lymph node mapping. Ann Surg Oncol 16(10):2943-2952. doi: 10.1245/s10434-009-0594-2
34. Marshall MV, Draney D, Sevick-Muraca EM, Olive DM (2010) Single-dose intravenous toxicity study of IRDye 800CW in Sprague-Dawley rats. Mol Imaging Biol 12(6):583-594. doi: 10.1007/s11307-010-0317-x
35. Sandanaraj BS, Gremlich HU, Kneuer R, Dawson J, Wacha S (2010) Fluorescent nanoprobes as a biomarker for increased vascular permeability: implications in diagnosis and treatment of cancer and inflammation. Bioconjug Chem 21(1):93-101. doi: 10.1021/bc900311h
36. Proulx ST, Luciani P, Derzsi S, Rinderknecht M, Mumprecht V, Leroux JC, Detmar M (2010) Quantitative imaging of lymphatic function with liposomal indocyanine green. Cancer Res 70(18):7053-7062. doi: 10.1158/0008-5472.CAN-10- 0271
37. Greenwald RB, Choe YH, McGuire J, Conover CD (2003) Effective drug delivery by PEGylated drug conjugates. Adv Drug Deliv Rev 55(2):217-250
38. Fox ME, Szoka FC, Frechet JM (2009) Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture. Acc Chem Res 42(8):1141-1151. doi: 10.1021/ar900035f
39. Huggenberger R, Ullmann S, Proulx ST, Pytowski B, Alitalo K, Detmar M (2010) Stimulation of lymphangiogenesis via VEGFR-3 inhibits chronic skin inflammation. J Exp Med 207(10):2255-2269. doi: 10.1084/jem.20100559
40. Zhou Q, Guo R, Wood R, Boyce BF, Liang Q, Wang YJ, Schwarz EM, Xing L (2011) Vascular endothelial growth factor C attenuates joint damage in chronic inflammatory arthritis by accelerating local lymphatic drainage in mice. Arthritis Rheum 63(8):2318-2328. doi: 10.1002/art.30421
41. Saaristo A, Tammela T, Farkkila A, Karkkainen M, Suominen E, Yla-Herttuala S, Alitalo K (2006) Vascular endothelial growth factor-C accelerates diabetic wound healing. Am J Pathol 169(3):1080-1087. doi: 10.2353/ajpath.2006.051251
42. Baluk P, Tammela T, Ator E, Lyubynska N, Achen MG, Hicklin DJ, Jeltsch M, Petrova TV, Pytowski B, Stacker SA, Yla-Herttuala S, Jackson DG, Alitalo K, McDonald DM (2005) Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation. J Clin Invest 115(2):247-257. doi: 10.1172/JCI22037
43. Proulx ST, Kwok E, You Z, Beck CA, Shealy DJ, Ritchlin CT, Boyce BF, Xing L, Schwarz EM (2007) MRI and quantification of draining lymph node function in inflammatory arthritis. Ann N Y Acad Sci 1117:106-123. doi: 10.1196/annals.1402. 016
44. Greish K (2007) Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines. J Drug Target 15(7-8):457-464. doi: 10.1080/10611860701539584
45. Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7(11):653-664. doi: 10.1038/nrclinonc.2010.139
46. Witzenbichler B, Asahara T, Murohara T, Silver M, Spyridopoulos I, Magner M, Principe N, Kearney M, Hu JS, Isner JM (1998) Vascular endothelial growth factor-C (VEGF-C/VEGF-2) promotes angiogenesis in the setting of tissue ischemia. Am J Pathol 153(2):381-394. doi: 10.1016/S0002-9440(10)65582-4
47. Saaristo A, Veikkola T, Enholm B, Hytonen M, Arola J, Pajusola K, Turunen P, Jeltsch M, Karkkainen MJ, Kerjaschki D, Bueler H, Yla-Herttuala S, Alitalo K (2002) Adenoviral VEGF-C overexpression induces blood vessel enlargement, tortuosity, and leakiness but no sprouting angiogenesis in the skin or mucous membranes. FASEB J 16(9):1041-1049. doi: 10.1096/fj.01-1042com